How Gendered Social Norms Shape Women’s Vaccine Uptake Across the Life Course
A vaccine appointment can look like a simple health decision. For many women, it is rarely that simple. It may depend on who controls the household money, whether a clinic is seen as “appropriate” for young unmarried girls, whether a mother can leave work, whether an older woman believes her own health still matters, and whether family members support or question the choice.
Vaccines protect people at every stage of life, but uptake does not happen in a vacuum. Gendered social norms shape who gets information, who gets permission, who has time to travel, and whose pain or risk is taken seriously. These norms do not affect all women in the same way. Caste, class, disability, religion, rural residence, migration status, education, marital status, and access to phones or transport all change the picture.
The result is a pattern seen across countries, including India: women often act as the health managers of families, yet face barriers when seeking care for themselves.
Gender norms shape vaccine decisions before a woman reaches the clinic
Health programmes often assume that if vaccines are available, people will come. Gender norms show why that assumption falls short.
In many households, women are expected to manage children’s health, elder care, cooking, water collection, paid work, and unpaid work. These duties can make their own healthcare feel optional or easy to postpone. A mother may take her child for immunisation on schedule, but delay her own tetanus, influenza, COVID-19, HPV, or other recommended vaccines because there is always another household task to finish.
Several common expectations shape vaccine decisions.
Women should put family first.
This can increase childhood vaccine uptake, because mothers are often held responsible for children’s health. Yet it can reduce adult women’s uptake when their own prevention is seen as less urgent.
Men or elders should approve major decisions.
In some households, women may need a husband, father, mother-in-law, or community elder to agree before they travel, spend money, or accept a vaccine. This matters even more for adolescent girls and newly married women.
Good women should avoid topics linked to sexuality.
The HPV vaccine prevents infections that can lead to cervical cancer, but because HPV is sexually transmitted, some families worry that vaccination will be seen as permission for sexual activity. This stigma can delay or block protection for adolescent girls, even though the vaccine works best before exposure to the virus.
Pregnant women should avoid all “risks”.
Pregnancy can make families more cautious about medicines and vaccines. That caution is understandable, but misinformation can turn caution into refusal, even for vaccines that health authorities recommend during pregnancy to protect both mother and baby.
Older women should endure illness quietly.
After reproductive age, women’s health needs can become less visible. Older women may be less likely to seek vaccines for influenza, pneumococcal disease, shingles, or other adult conditions, especially if they depend on others for transport or money.
These are not just “beliefs”. They are social rules with practical effects.
The life course view shows where barriers appear
A life course approach helps explain why vaccine uptake changes from childhood to older age. The same woman may face different pressures at different stages.
Girls may depend on schools, parents, and community consent
For girls, vaccination often depends on school attendance and parental consent. School-based programmes can work well because they reduce travel costs and reach girls in a familiar setting. They can also miss girls who are out of school, absent during campaigns, working, married early, or living in conflict-affected or migrant communities.
HPV vaccination shows this clearly. The World Health Organization’s cervical cancer elimination strategy calls for 90% of girls to be fully vaccinated against HPV by age 15. Yet global HPV coverage remains far below that goal. WHO and UNICEF estimates in recent years have placed first-dose HPV coverage among girls at roughly a quarter to a third worldwide, with lower coverage in many low- and middle-income settings.
The gap is not only about supply. It is also about whether families see girls’ future health as worth protecting now.
Adolescents face silence around sexual and reproductive health
Adolescence is a crucial window for HPV and other vaccines, but it is also a stage where girls may have the least voice. If parents see vaccine information as “too adult”, health workers may avoid discussing it clearly. If unmarried girls are expected to appear sexually innocent, families may reject a vaccine linked to sexual transmission.
This silence can be harmful. Cervical cancer is one of the leading cancers among women in India. GLOBOCAN 2022 estimates suggest India sees about 1.27 lakh new cervical cancer cases and nearly 80,000 deaths each year. Most cervical cancers are linked to persistent HPV infection, which makes prevention through vaccination and screening a major public health opportunity.
Pregnancy creates both opportunity and pressure
Pregnancy often brings women into contact with the health system. Antenatal care can increase uptake of tetanus-containing vaccines and other recommended vaccines because women meet nurses, doctors, and community health workers.
India’s progress against maternal and neonatal tetanus shows what is possible. The country was validated as having eliminated maternal and neonatal tetanus in 2015, after years of immunisation, cleaner delivery practices, and stronger antenatal care. This success depended not only on vaccine supply, but on reaching pregnant women through public health systems and community workers.
At the same time, pregnancy brings pressure. Families may fear side effects more than disease. A woman may be blamed if anything goes wrong later in pregnancy, even when the vaccine had nothing to do with it. That fear can make refusal feel safer than acceptance.
Mothers often protect others while postponing themselves
After childbirth, women are frequently expected to manage immunisation visits for children. Programmes rightly focus on children, but the mother’s own health can fade into the background. Postpartum women may need catch-up vaccines, COVID-19 vaccination, influenza vaccination where recommended, or counselling for future HPV screening and prevention. Yet clinics may treat them mainly as caregivers.
This is a missed chance. A child’s immunisation visit can also be a respectful moment to ask the mother what she needs.
Older women face invisibility in adult immunisation
Adult vaccination remains less routine than childhood immunisation in many places. For older women, barriers can include low awareness, limited income, widowhood, mobility problems, and the belief that illness is part of ageing. Women who spent decades caring for others may not feel entitled to preventive care.
If adult vaccine messages focus only on people with formal jobs, private doctors, or urban lifestyles, they miss many older women.
Case studies show that norms can be changed
Vaccine uptake improves when programmes work with social realities rather than pretending they do not exist.
Rwanda’s HPV programme treated community trust as central
Rwanda is often cited for achieving high HPV vaccine coverage after introducing a national school-based programme. Reports have shown coverage reaching high levels, often above 90% in early programme years. The results came from more than vaccine availability. The programme used schools, community engagement, teacher involvement, and public messaging to build trust.
The lesson is clear: when families understand why adolescent girls need protection, and when vaccination is delivered through trusted systems, stigma can fall.
This matters for India and other countries planning or expanding HPV vaccination. The vaccine cannot be framed only as a medical product. It must be framed as cancer prevention, girls’ future health, and a routine part of adolescent care.
India’s maternal tetanus progress shows the value of contact points
India’s elimination of maternal and neonatal tetanus shows how antenatal care, trained birth attendance, and community outreach can shift outcomes at scale. Accredited Social Health Activists, auxiliary nurse midwives, Anganwadi workers, and primary health systems have helped connect pregnant women with preventive care.
Still, success in one area does not remove all gender barriers. Tetanus vaccination in pregnancy often fits a socially accepted role: protecting the baby. Vaccines seen as protecting the woman herself may receive less support. Programmes need to value women’s health directly, not only through motherhood.
COVID-19 revealed digital and gender gaps
During the COVID-19 vaccine rollout, India built one of the world’s largest vaccination campaigns. It also revealed early gender gaps. In several phases, men received more doses than women, especially where online registration, travel distance, wage loss, and misinformation created barriers. The gap later narrowed with walk-in access, local camps, and community outreach.
The case shows how a “neutral” system can affect women differently. A digital booking platform may look fair, but not if women have less access to phones, internet, identification documents, or free time. NFHS-5 found that only around half of women in India owned and used a mobile phone themselves, with wide variation across states and social groups. That matters when health access depends on digital information.
The barriers are practical, social, and emotional
Vaccine hesitancy is often described as a knowledge problem. Knowledge matters, but it is only one part of the story.
Common barriers include:
Time poverty Women may not be able to leave domestic work, paid work, childcare, or elder care.
Limited mobility Distance, safety concerns, poor transport, and social restrictions can stop women from reaching clinics.
Household decision-making Permission, money, and support may rest with husbands, parents, or in-laws.
Poorly timed services Clinics open during working hours can exclude women in informal work or those who cannot leave home during the day.
Cost concerns Even when the vaccine is free, travel, lost wages, meals, and childcare cost money.
Misinformation and fear Rumours about infertility, miscarriage, sexual behaviour, or long-term harm can spread quickly.
Low trust in health systems Past disrespect, rushed counselling, discrimination, or poor treatment can reduce acceptance.
Lack of privacy Adolescents and young women may avoid services if they fear gossip or moral judgement.
These barriers overlap. A woman may accept the value of a vaccine, want it, and still miss it.
Better vaccine programmes must be designed around women’s lives
Improving uptake requires more than saying “raise awareness”. Awareness campaigns fail when they ignore childcare, mobility, safety, trust, and power inside households.
Bring vaccines closer to daily life
Outreach sessions, school-based programmes, mobile clinics, workplace camps, and village health and nutrition days can reduce travel and time costs. For urban poor communities, sessions near informal settlements, markets, construction sites, and domestic work hubs can reach women who rarely attend formal clinics.
Flexible hours matter too. Early morning, evening, or weekend sessions can help women who cannot leave at standard clinic times.
Speak to families, not only individual women
Many women do not make vaccine decisions alone. Programmes should include husbands, mothers-in-law, fathers, teachers, faith leaders, and local women’s groups without taking agency away from women.
For HPV vaccination, messages should focus on cancer prevention and long-term health. For pregnancy vaccines, counselling should explain both benefits and expected side effects in plain language. For older women, messaging should challenge the idea that preventive care is only for children.
Train health workers to counsel without judgement
A trusted health worker can change a decision. A dismissive one can harden refusal.
Training should help providers:
explain benefits and risks clearly
answer fertility and pregnancy concerns without ridicule
protect adolescent privacy
avoid moralising about sexuality
recognise domestic barriers that affect attendance
invite questions instead of rushing consent
Community health workers often carry the heaviest load in this work. They need fair pay, supportive supervision, transport, safety, and updated information.
Use data that can reveal gender gaps
Health systems should track vaccine uptake by age, sex, geography, disability, pregnancy status where relevant, and social factors where ethically collected. Data should not just sit in reports. It should guide outreach.
If adolescent girls in one block are missing HPV doses, the reason may be school dropout. If pregnant women miss doses, the reason may be antenatal care access. If older women lag behind men, the reason may be mobility, cost, or low awareness.
Make services respectful and safe
Respect is not a soft issue. It affects uptake.
Women are more likely to return when clinics offer privacy, clear information, shorter waits, safe spaces for adolescents, and staff who do not shame them. Complaint systems, women-friendly clinic timings, and local feedback meetings can improve trust.
Connect vaccination with broader women’s health
Vaccines should not be isolated from other services. HPV vaccination can connect with menstrual health education and later cervical cancer screening. Pregnancy vaccines can connect with antenatal nutrition and birth planning. Adult vaccines can connect with chronic disease care.
This approach treats women as whole people, not just mothers or caregivers.
The strongest message is simple
Gendered social norms can block vaccine uptake, but they can also support it when programmes engage families, communities, and health workers with care. The goal is not to blame culture or families. The goal is to see the real conditions under which women make health decisions.
A fair vaccine programme asks better questions. Who has time to attend? Who controls transport? Who receives information? Who needs permission? Who fears judgement? Who is missing from the clinic queue?
When those questions shape policy, vaccination becomes easier to accept and easier to access. Women’s vaccine uptake is not only a matter of individual choice. It is a measure of whether health systems recognise women’s lives in full.
Comments